QCG
HALO icon

Quadrant Capital Group’s Halozyme HALO Stock Holding History

Quadrant Capital Group’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$687K Buy
8,780
+157
+2% +$10.7K 0.02% 741
2026
Q1 		$557K Buy
8,623
+427
+5% +$30.1K 0.02% 859
2025
Q4 		$552K Sell
8,196
-309
-4% -$20.8K 0.02% 868
2025
Q3 		$624K Buy
8,505
+293
+4% +$19.5K 0.02% 752
2025
Q2 		$427K Sell
8,212
-654
-7% -$37.2K 0.02% 969
2025
Q1 		$566K Buy
8,866
+7,188
+428% +$418K 0.02% 659
2024
Q4 		$80.2K Sell
1,678
-146
-8% -$7.49K 0.01% 1174
2024
Q3 		$104K Buy
1,824
+85
+5% +$4.87K 0.01% 1044
2024
Q2 		$91.1K Hold
1,739
– – 0.01% 1067
2024
Q1 		$70.7K Sell
1,739
-1,675
-49% -$62.8K 0.01% 1183
2023
Q4 		$126K Buy
3,414
+624
+22% +$23.5K 0.01% 856
2023
Q3 		$107K Buy
2,790
+122
+5% +$5K 0.01% 832
2023
Q2 		$96.2K Buy
2,668
+1,634
+158% +$55.8K 0.01% 899
2023
Q1 		$39.5K Buy
1,034
+74
+8% +$3.47K ﹤0.01% 1368
2022
Q4 		$54.6K Buy
960
+506
+111% +$25.9K 0.01% 1118
2022
Q3 		$18K Buy
454
+2
+0.4% +$88 ﹤0.01% 1605
2022
Q2 		$20K Buy
452
+93
+26% +$4.02K ﹤0.01% 1306
2022
Q1 		$14K Buy
359
+129
+56% +$4.59K ﹤0.01% 1495
2021
Q4 		$9K Buy
230
+73
+46% +$2.73K ﹤0.01% 1667
2021
Q3 		$6K Buy
157
+33
+27% +$1.38K ﹤0.01% 1800
2021
Q2 		$6K Buy
124
+3
+2% +$133 ﹤0.01% 1774
2021
Q1 		$5K Buy
121
+13
+12% +$593 ﹤0.01% 1775
2020
Q4 		$5K Hold
108
– – ﹤0.01% 1690
2020
Q3 		$3K Buy
108
+14
+15% +$390 ﹤0.01% 1714
2020
Q2 		$3K Sell
94
-1,959
-95% -$44.2K ﹤0.01% 1802
2020
Q1 		$36K Buy
2,053
+11
+0.5% +$209 0.01% 1023
2019
Q4 		$35K Buy
+2,042
New +$35.4K ﹤0.01% 1497
2016
Q1 		– Sell
-354
Closed -$6K – 1873
2015
Q4 		$6K Buy
+354
New +$5.64K ﹤0.01% 983

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Quadrant Capital Group's HALO Position: Q2 2026 in Review

Quadrant Capital Group increased its Halozyme (HALO) stake by 1.8% in Q2 2026, buying an estimated $10.7K and bringing the position to 8,780 shares worth $687K. The position accounts for 0.02% of the portfolio, ranked #741.

Quadrant Capital Group first reported a position in HALO in Q4 2015 and has held it in 28 quarters since. 673 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Quadrant Capital Group held 8,780 shares of Halozyme worth $687K as of Q2 2026.
  • Quadrant Capital Group bought 157 Halozyme shares in Q2 2026, an estimated $10.7K.
  • Halozyme made up 0.02% of Quadrant Capital Group's portfolio in Q2 2026, its #741 holding.
  • Quadrant Capital Group first reported a position in Halozyme in Q4 2015 and has held it in 28 quarters since.
  • 673 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.